This journal activity provides practitioners with a review of updates in key treatment approaches, particularly with respect to the role of radiotherapy.

IJROBP Journal SA-CME activity for March 15, 2021 provides the clinician with important knowledge on new clinical trials as well as ASTRO practice statements have emerged over the past 5 years that may impact how palliative radiation therapy for bone metastases is used.

IJROBP Journal SA-CME activity for March 1, 2021 provides the clinician with important clinical and pre-clinical context as to the significant technical and procedural facets that must be considered for safe and effective implementation of cardiac radioablation for cardiac arrhythmias.

This journal activity provides practitioners with a review of updates in key treatment approaches, particularly with respect to the role of radiotherapy.

IJROBP Journal SA-CME activity for January 1, 2021 provides practitioners with information to improve the informed consent process for both standard treatment and clinical trial enrollment.

IJROBP Journal SA-CME activity for December 1, 2020 provides practitioners some practical knowledge needed to counsel patients in the setting of various treatment regimens in the management of localized prostate carcinoma.

This journal activity provides practitioners with the knowledge about closing the practice gap in outlining safety concerns when MRI is integrated into radiation oncology departments.

IJROBP Journal SA-CME activity for November 15, 2020 provides practitioners some practical knowledge on the role of the immune system on tumor activity is an area of active research. Radiation therapy is one possible method of further modulating this response.

IJROBP Journal SA-CME activity for November 1, 2020 provides practitioners some practical knowledge about a hypofractionated regimen for small cell lung cancer that was found to have comparable survival and toxicity outcomes to conventionally fractionated radiotherapy.

IJROBP Journal SA-CME activity for October 1, 2020 provides practitioners with information regarding the combination of radiotherapy and modern checkpoint inhibition immunotherapy.